| 摘要: |
| 近年来热度骤增的生物制品药物对诸多疾病疗效斐然,在药品市场中所占比重也是节节攀升。生物制品与之俱来的生物安全性问题于是被渐渐提上日程,其中宿主细胞残留DNA由于可能会传递肿瘤或病毒相关基因,存在潜在的危险性,各国药品监督管理机构对其残留量有着严格的限度控制。同时,各国药典也陆续提供数种关于宿主细胞残留DNA检测经典的方法,目前以实时定量PCR方法为最优,因其专一性强、灵敏度高、快速且可实现高通量。本文介绍了一些国内与国外监管机构出台的关于生物制品宿主细胞残留DNA检测的限定规定,并对现有的常见检测方法进行描述、总结和比较。 |
| 关键词: 生物制品;宿主细胞残留DNA 实时定量聚合酶链式反应 |
| DOI:10.13506/j.cnki.jpr.2018.02.014 |
| 基金项目: |
|
|
|
| Detection of host cells residual DNA in biological drugs |
| JIA Huiyan,YAO Xuejing |
| (RemeGen Ltd.,Yantai 264006,China) |
| Abstract: |
| In recent years, the bio-drugs have striking effects on kinds of diseases and a rising proportion in drug market. Then the bio-safety problem of bio-drugs is put on the agenda gradually. The host cell residual DNA is potentially dangerous due to the transmission possibility of tumor or virus-related genes, so most national drug regulatory authorities have strict control of it. At the same time, the national pharmacopoeia has also provided several kinds of classical methods for host cells residual DNA detection. The best method is real-time quantitative PCR currently, because of its specificity, high sensitivity, fast and high throughput. The article briefly introduced the limits of residual DNA detection issued by several national regulatory authorities, and then summarized and compared the existing common detection methods. |
| Key words: Biological drug Host cell residual DNA Real-time quantitative PCR |